← Eichor
Study identifier: NCT06168058 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

Condition: Chronic Pelvic Pain Syndrome · Pelvic Pain · Pelvic Varices  ·  Sponsor: Weill Medical College of Cornell University

PhaseNA
Planned participants40
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersYes

About this study

The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with chronic pelvic pain and pelvic varicose veins. The data gathered will assist in addressing changes in quality of life in patients who have ovarian/pelvic vein embolization versus no embolization.

This description comes directly from the study's public registry record.

Talk to the study team

Neil M Khilnani, MD  ·  646-962-9179  ·  EMBOLIZE@med.cornell.edu

Sasha Garcia  ·  sag2958@med.cornell.edu

Always discuss trial participation with your own doctor first.

Locations (4)

Northwell Health Physician Partners Vascular SurgeryNew Hyde Park, New York, United StatesRecruiting
Weill Cornell MedicineNew York, New York, United StatesRecruiting
UNC School of MedicineChapel Hill, North Carolina, United StatesRecruiting
Lake Washington VascularBellevue, Washington, United StatesWithdrawn

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06168058